3D Bioprinting for Tumor Microenvironment Reconstruction: Advances, Challenges, and Future Perspectives

Area of Science:

• Biomedical Engineering
• Cancer Research
• Oncology

Background:

• Current cancer research models, including 2D cultures and animal models, have limitations in replicating the in vivo tumor microenvironment (TME).
• Existing 3D in vitro platforms (spheroids, organoids, organ-on-chip) improve physiological relevance but often lack spatial control and reproducibility.
• A significant gap exists between preclinical findings and clinical outcomes in oncology due to inadequate model systems.

Purpose of the Study:

• To highlight the potential of 3D bioprinting in cancer research.
• To discuss how 3D bioprinting can overcome limitations of existing models for TME reconstruction.
• To explore applications and future directions of 3D bioprinting in oncology.

Main Methods:

• Review of technical foundations for TME reconstruction using 3D bioprinting.
• Discussion of bioink design, printing strategies, and complex tumor model construction.
• Summarization of applications in tumor biology, drug screening, and personalized therapy.

Main Results:

• 3D bioprinting enables reproducible integration of TME complexity within a controllable spatial framework.
• It offers a superior approach to existing 3D models for capturing TME intricacies.
• The technology facilitates advanced applications in cancer research and drug development.

Conclusions:

• 3D bioprinting is a transformative technology for cancer research, offering unprecedented control over TME reconstruction.
• It holds significant promise for improving drug screening accuracy, developing personalized therapies, and enhancing preclinical evaluations.
• Further interdisciplinary integration and research are crucial for realizing the full potential of 3D bioprinting in precision oncology.